Global Market Overview
The global GERD Drug and Devices market size was valued at US$ 4.01 Bn. in 2022 and is projected to reach US$ 4.71 Bn. by 2029, growing at a compound annual growth rate (CAGR) of 2.3% during the forecast period.
Market Overview
A comprehensive analysis of the global GERD Drug and Devices market was conducted through extensive primary and secondary research. Secondary research was utilized to enhance the existing data, segment the market, determine its overall size, and forecast both the market size and growth rate.
Get Free Sample: https://www.maximizemarketresearch.com/request-sample/21535/
Market Scope
At Maximize, our team gathers market data and insights from multiple sources to offer a detailed regional analysis. The country-level assessment within the study is based on evaluations of regional stakeholders, tax regulations, policies, consumer behavior, and macroeconomic data.
Drivers and Restraints
The GERD Drug and Devices market report also addresses the major drivers and restraints impacting the market.
Segmentation
The market is segmented into various categories
by Type
• Antacids
• H2 Receptor Blockers
• Proton Pump Inhibitors
• Pro-Kinetic Agents
by Devices
• Digitrapper
• Bravo System
• Stretta
• Linx Reflux Management System
• Medigus Ultrasonic Surgical Endostapler
• Other Devices
by Region
• North America (United States, Canada and Mexico)
• Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
• Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
• Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
• South America (Brazil, Argentina Rest of South America)
Key Players
Some of the prominent players in the GERD Drug and Devices market include:
• AstraZeneca PLC
• Boston Scientific Corporation
• Cempra Inc.
• Eisai Co., Ltd.
• EndoGastric Solutions Inc.
• EndoStim Inc.
• GlaxoSmithKline Plc
• Ironwood Pharmaceuticals, Inc.
• Jeil Pharmaceutical Co. Ltd.
• Johnson & Johnson
• Mederi Therapeutics Inc.
• Medigus Ltd.
• Medtronic Inc.
• Merck & CO., Inc.
• Novartis AG
• Pfizer Inc.
• Takeda Pharmaceutical Company Limited
• Teva Pharmaceuticals Industries Limited.
• Torax Medical
• Valeant Pharmaceuticals International, Inc
For More Info, Click Here: https://www.maximizemarketresearch.com/market-report/gerd-drug-and-devices-market/21535/
Regional Analysis
The report provides a country-level analysis of the GERD Drug and Devices market, highlighting regions with significant market share and high growth potential. The regions covered include North America (USA, Canada), South America, Asia Pacific (China, Japan, India, Korea), Europe (Germany, UK, France, Italy), and other regions.
COVID-19 Impact Analysis
The report includes an analysis of the impact of COVID-19 on the global GERD Drug and Devices market.
Key Questions Answered in the Report
- Which product segment held the largest share in the GERD Drug and Devices market in 2020?
- What is the projected competitive landscape of the GERD Drug and Devices market for the forecast period (2021-2027)?
- What are the key factors driving the growth of the GERD Drug and Devices market?
- Which region held the maximum market share in 2020?
- What will be the CAGR of the global GERD Drug and Devices market during the forecast period (2021-2027)?
About Maximize Market Research
Maximize Market Research is a diverse market research and consulting firm with expertise across various industries. Our areas of focus include medical devices, pharmaceuticals, science and engineering, electronics, industrial equipment, technology, automotive, chemicals, consumer goods, beverages, personal care, and automation. We offer market-verified industry insights, technical trend analyses, strategic advisory services, competitive analysis, production and demand assessments, and client impact studies.
Contact Us
Maximize Market Research
3rd Floor, Navale IT Park, Phase 2
Pune-Bangalore Highway, Narhe,
Pune, Maharashtra 411041, India
Email: sales@maximizemarketresearch.com
Phone: +91 96071 95908, +91 9607365656